The treatment of wet AMD in Canada: access to therapy (policy review).

Full Abstract

Age-related macular degeneration (AMD) is the leading cause of blindness in North America, affecting 2 million Canadians older than age 50 years. AMD is subdivided into 2 types: an atrophic form, so-called "dry" AMD, and an exudative or "wet" form, characterized by the presence of choroidal neovascularization (CNV). Since 2000, after decades with no effective therapy aside from thermal obliterative laser treatment of CNV, 3 new treatments have been approved, each offering significant therapeutic advances at increasingly higher prices, and in an increasingly cost-containment-oriented payer environment. Many of Canada's public drug plans have been relatively slow to fund evidence-based, approved treatments. This paper reviews the disease, as well as the current private and public coverage for wet AMD treatments.

Author information

Author/s: Cruess, Alan (A); Maberley, David (D); Wong, David (D); Chen, John (J);

Affiliation: Department of Ophthalmology, Dalhousie University, Halifax, NS. alan.cruess(-atsign-)dal.ca

Journal and publication information

Publication Type: Journal Article; Review

Journal: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie (Can J Ophthalmol), published in Canada. (Language: eng)

Reference: 2009-Oct; vol 44 (issue 5) : pp 548-56

Dates: Created 2009/09/30; Completed 2009/10/22;

PMID: 19789590, status: MEDLINE (last retrieval date: 10/22/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.